Related Experiment Video
Updated: Jul 7, 2026

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
Published on: September 22, 2011
Assessment of cell engineering strategies for improved therapeutic protein production in CHO cells
Chaya Mohan1, Yeon-Gu Kim, Jane Koo
1Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejon, Korea.
Abstract:
Recombinant glycoprotein therapeutics have proven to be invaluable pharmaceuticals for the treatment of various diseases. Chinese hamster ovary (CHO) cells are widely used in industry for the production of these proteins. Several strategies for engineering CHO cells for improved protein production have been tried with considerable results. The focus has mainly been to increase the specific productivity and to extend the culture longevity by preventing programmed cell death. These CHO cell engineering strategies, particularly those developed in Korea, are reviewed here.
More Related Videos
Related Concept Videos
Upstream Processing
Bioreactor Controls-III

